RenBio Revenue and Competitors

Location

$38M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • RenBio's estimated annual revenue is currently $1M per year.(i)
  • RenBio's estimated revenue per employee is $77,500
  • RenBio's total funding is $38M.

Employee Data

  • RenBio has 13 Employees.(i)
  • RenBio grew their employee count by 0% last year.

RenBio's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
Co-FounderReveal Email/Phone
3
Director ResearchReveal Email/Phone
4
COO & Chief Development OfficerReveal Email/Phone
5
President & Chief Scientific OfficerReveal Email/Phone
6
Senior Project ManagerReveal Email/Phone
7
Senior Research EngineerReveal Email/Phone
8
Research Associate IIReveal Email/Phone
9
Senior Research EngineerReveal Email/Phone
10
Research Associate IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is RenBio?

RenBio was founded on the principle that the remarkable medical benefits of antibody therapeutics should be available to everyone, and was named one of DARPA’s “Biotech Startups of the Future” one year after opening its operations. The company was co-founded by David D. Ho, MD (Time magazine's \Man of the Year\ in 1996 and recipient of the Presidential Citizens Medal) and Yaoxing Huang, PhD, visionary scientists affiliated with the Aaron Diamond AIDS Research Center and Professors at Columbia University Medical Center. RenBio is backed by the Bill & Melinda Gates Foundation, DARPA, and a syndicate of private investors, and is headquartered at the Alexandria Center® for Life Science in New York City.

keywords:N/A

$38M

Total Funding

13

Number of Employees

$1M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.8M13-19%$9.6M
#2
$0.4M13-13%$116.4M
#3
$0.4M13-28%$12.6M
#4
$1.6M13N/AN/A
#5
$1.6M13N/AN/A